Clinical Trial Update: Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease [Phase 1]

View source ↗

Summary

Clinical Trial Update notes that MTX-439 is in a Phase 1 trial in healthy adults and adults with diabetic kidney disease and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• MTX-439

Snippet

Sponsor: Mediar Therapeutics | Conditions: Healthy Adult Participants, Diabetic Kidney Disease | Phase 1 | Status: NOT_YET_RECRUITING